Market Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zydus launched the drug under the brand names Lipaglyn and Bilypsa and will continue to market them. Lupin will pay Zydus upfront licensing fees and milestone payments based on the achievement of pre-defined milestones. With a once-daily, 4mg dose regimen, Saroglitazar Mg enables better compliance, reduces pill burden, and offers greater convenience for patients.

Sharvil patelSun pharmaZydus lifesciencesNilesh guptaNon alcoholic fatty liver diseaseNon alcoholic steato hepatitisDiabetes mellitusMarket drugTreat liverTreat diseaseLiver disease